Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2009
10/28/2009EP2111231A2 Methods and compositions for improving immune responses
10/28/2009EP2111230A2 Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis
10/28/2009EP2111121A2 Methods and compositions for enhancing growth of fish and shellfish
10/28/2009EP2029170B1 Quality control methods for oil-in-water emulsions containing squalene
10/28/2009EP1899378B1 Il-1 beta binding antibodies and fragments thereof
10/28/2009EP1888625B1 Malaria vaccines
10/28/2009EP1624936B1 Cns chloride modulation and uses thereof
10/28/2009EP1548032B9 Kdr peptides and vaccines comprising the same
10/28/2009EP1474120B1 Antibody having a t-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
10/28/2009EP1436003B1 Taci-immunoglobulin fusion proteins
10/28/2009EP1346218B1 Tripeptide of fc gamma riia
10/28/2009EP1098908B1 Anti-ccr2 antibodies and methods of use therefor
10/28/2009EP1071758B1 Porcine adenovirus vector
10/28/2009EP1012232B1 Genetically modified tumor-targeted bacteria with reduced virulence
10/28/2009EP0983361B1 Bacterial pheromones and uses therefor
10/28/2009EP0915706B1 Screening methods for compounds useful in the regulation of body weight
10/28/2009CN101568647A Secretion of antibodies without signal peptides from bacteria
10/28/2009CN101568550A Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides
10/28/2009CN101568349A Methods of reducing phosphate absorption
10/28/2009CN101568348A Methods of disrupting quorum sensing to affect microbial population cell density
10/28/2009CN101565465A Surface antigen 1 of Toxoplasma gondii human antibody Fab fragment and encoded gene thereof
10/28/2009CN101565459A Streptococcus pneumoniae proteins and nucleic acid molecules
10/28/2009CN101565458A Peptide vaccine for animal and preparation method thereof
10/28/2009CN101565457A Synthetic peptide vaccine and preparation method thereof
10/28/2009CN101565455A CTL epitope polypeptides of bird flu H5N1 virus and applications thereof
10/28/2009CN101564535A Cancer treatment method
10/28/2009CN101564534A Specific yolk antibody preparation for controlling halitosis pathogens and application thereof
10/28/2009CN101564533A Hepatitis E protein-nucleic acid composite vaccine and preparation method thereof
10/28/2009CN100554279C Synthetic polysaccharide antigens for immunological intervention in disease
10/28/2009CN100554278C Human tumor M2-type pyruvate kinase antigen determinant polypeptide and antibody and their application in diagnositic kit
10/28/2009CN100553676C H9 sub-type fowl-flu HI stabilized antigen
10/27/2009USRE40948 APC antibodies
10/27/2009US7608698 Muscular disorders; cardiovascular disorders; cell transformed with nucleic acid; culture product
10/27/2009US7608696 Immunoglobulin for use in diagnosis and prognosis of metastatic breast cancer and degenerative neural conditions; drug screening; immunotherapy and diagnostics; anticarcinogenic agents
10/27/2009US7608694 Neutralizing antibody with specificity for antigenic determinants; infections (viral, bacterial, fungal and parasitic), endotoxic shock associtated with infection, arthritis, rheumatoid arthritis, pelvic inflammatory disease, Alzheimer's Disease, Crohn's disease
10/27/2009US7608691 Antibodies against IL-16 antagonist peptides
10/27/2009US7608685 Tumor antigen based on products of the tumor suppressor gene WT1
10/27/2009US7608683 Human leukocyte antigen pan DR-binding peptides for use in the treatment of infections, inflammatory, autoimmune and cancer diseases; has heat shock protein that is capable of binding to MHC class II molecules
10/27/2009US7608682 Substrates of N-end rule ubiquitylation and methods for measuring the ubiquitylation of these substrates
10/27/2009US7608681 Methods and compositions for prolonging elimination half-times of bioactive compounds
10/27/2009US7608452 Polynucleotides encoding cytokine receptor zcytor19
10/27/2009US7608451 Expression vector comprising kinase nucleotide sequence for use as tool in transformation and expression of heterologus genes in mamalian cells
10/27/2009US7608450 Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
10/27/2009US7608428 Polynucleotide encoding an IL-28B polypeptide
10/27/2009US7608427 Encoding polypeptide covalently attached with a polyethylene glycol propionaldehyde group having anti-hepatitis C activity
10/27/2009US7608422 Gene therapy; vaccines; inducing antibodies and/or cytotoxic or helper T lymphocytes
10/27/2009US7608413 Kidney disease targets and uses thereof
10/27/2009US7608409 Screening assay using G-protein coupled receptor protein OT7T175
10/27/2009US7608405 Distinguishing target adiponectin multimer from the other adiponectin multimers by using a protease and/or an antibody; accurately evaluate the relationship between a disease and adiponectin
10/27/2009US7608401 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis
10/27/2009US7608279 Stable oil in water emulsion containing deactivated immunogen such as Mycoplasma or circovirus with mineral and nonionic surfactant ; induce immunology response
10/27/2009US7608278 Less painful immunogenic composition of a hydrophobic protein; solubilizing hydrophobic protein with a zwitterionic detergent to make a composition that is then altered; meningitis or gonorrhea
10/27/2009US7608277 Tuberculosis nucleic acids, polypeptides and immunogenic compositions
10/27/2009US7608276 vaccines, immunogenic compositions; diagnostics, enzymatic studies and targets for antibiotics; for treating Staphylococcus aureus infection
10/27/2009US7608275 using a catheter to delivery an active neurotoxin botulinum light chain peptide through transdermal and applying energy to the targeted region, for treating a neuromuscular spasm and a respiratory disorders
10/27/2009US7608274 Therapeutic processes and useful compositions therefor
10/27/2009US7608273 glycoprotein cationic polypeptide as HIV vaccines; nontoxic
10/27/2009US7608272 Methods and compositions for vaccination of animals with PRRSV antigens with improved immunogenicity
10/27/2009US7608271 Modified human immunodeficiency virus anti-fusogenic GP41 peptides comprising a maleimide-containing group
10/27/2009US7608269 Compositions and methods for treating cancer by modulating HER-2 and EGF receptors
10/27/2009US7608268 Ferritin fusion proteins for use in vaccines and other applications
10/27/2009US7608267 Fusion protein of two different cytokines, one capable of enhancing a nonspecific immune response, and the other capable of enhancing a specific immunity; fusion protein of Interleukin-2 (Il-2) and IL-7 for example; use in immunotherapy such as cancer vaccine
10/27/2009US7608266 Yersinia species compositions
10/27/2009US7608265 Antibody or antigen binding fragment that binds acetyl-coA-acetyltransferase of Clostridium difficile
10/27/2009US7608264 Monoclonal antibody or antibody fragment which binds a pleiotrophin-binding fragment of human Anaplastic Lymphoma Kinase (ALK) and inhibits a pleiotrophin-mediated activity; prevents pleiotrophin-mediated neoplastic or mitogenic activity
10/27/2009US7608263 RG1 antibodies and uses thereof
10/27/2009US7608262 Such as antibodies; treating acute mycocardial infarction, deep vein thrombosis, stroke and thrombophlebitis
10/27/2009US7608260 Stabilized immunoglobulins
10/27/2009US7608259 Methods of cancer diagnosis and therapy targeted against a cancer stem line
10/27/2009US7608257 Using a reovirus and chemotherapeutic agents to treat ras-activated neoplastic cells; proliferative disorders
10/27/2009US7608247 vaccinating a mammal to produce a polyclonal antibody against Escherichia coli infection in central nervous system and/or peripheral blood circulation, comprises administering to the mammal an effective amount of an outer membrane protein A (OmpA) of Escherichia coli
10/27/2009US7608241 Radiolabeling method
10/27/2009CA2328904C Novel (poly)peptides which represent the epitopes of the human herpesvirus type 8
10/27/2009CA2148492C Bovine heat shock promoter and uses thereof
10/27/2009CA2146145C Immunogenic meningococcal lps and outer membrane vesicles and vaccine therefrom
10/27/2009CA2067205C Vaccine and immune serum against drugs of abuse
10/24/2009CA2665510A1 Novel formulations of tumour-associated peptides binding to human leukocyte antigen (hla) class i or ii molecules for vaccines
10/22/2009WO2009129502A2 Immunotherapies employing self-assembling vaccines
10/22/2009WO2009129498A2 Substance p and analogs thereof as a cancer immunogenic composition adjuvant
10/22/2009WO2009129476A2 An antibody bound synthetic vesicle containing active agent molecules
10/22/2009WO2009129374A2 Methods and compositions for preventing adhesion
10/22/2009WO2009128963A2 Cross-neutralizing human monoclonal antibodies to sars-cov and methods of use thereof
10/22/2009WO2009128952A2 Compositions of papillomavirus proteins and methods of use
10/22/2009WO2009128950A2 Deletion mutants of flagellin and methods of use
10/22/2009WO2009128949A2 Compositions of dengue viral proteins and methods of use
10/22/2009WO2009128948A1 Design and synthesis of directed sequence polymer compositions and antibodies thereof for the treatment of protein conformational disorders
10/22/2009WO2009128932A1 Delivery of lfa-1 antagonists to the gastrointestinal system
10/22/2009WO2009128878A1 CHIMERIC PORCINE CIRCOVIRUS PCV2Gen-1Rep AND USES THEREOF
10/22/2009WO2009128867A2 Recombinant biologically contained filovirus
10/22/2009WO2009128772A1 Stable amyloid beta monomers and oligomers
10/22/2009WO2009127988A1 Method and vaccine for optimizing the specific immune responses
10/22/2009WO2009127881A1 Anti-areg/hb-egf antibodies and treatment
10/22/2009WO2009127684A1 Vaccine for protection against lawsonia intracellularis, mycoplasma hyopneumoniae and porcine circo virus
10/22/2009WO2009127677A1 Vaccine
10/22/2009WO2009127676A1 Vaccine
10/22/2009WO2009127619A1 Methods for the treatment, the prognostic assessment and the staging of non-small cell lung cancer
10/22/2009WO2009127537A1 Post release modification of viral envelopes
10/22/2009WO2009127519A1 Compositions comprising antibodies or antibody fragments
10/22/2009WO2009127094A1 The elisa kit for detecting lincomycin
10/22/2009WO2009127046A1 Prostate specific membrane antigen antibodies and antigen binding fragments
1 ... 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 ... 1823